Patients with high HCC risk and underexpressed EpCAM phenotypes (such as HCC44 and HCC35) may warrant special attention, as their CTCs might transition to a more invasive mesenchymal phenotype through the EMT process, which is associated with a high risk of metastasis. This evidence concerns the gene EPCAM and hepatocellular carcinoma.